What does Huron Consulting Group do?
Huron Consulting Group Inc. is a Nasdaq-listed professional services firm that helps organizations redesign strategy, operations, technology, finance, and workforce models. It concentrates on complex institutions: health systems improving revenue cycle and care delivery, universities modernizing research administration and enterprise systems, and commercial or public-sector organizations navigating regulation and transformation. The company's 2025 Form 10-K describes three industry segments and two cross-company capabilities, placing Huron between global generalists and narrow specialists.
Which clients and services define the company?
Healthcare is the anchor. Huron serves health systems, hospitals, physician groups, payors, and post-acute providers through performance improvement, revenue-cycle managed services, strategy, enterprise technology, data, automation, and software. Education serves universities, research institutes, and nonprofits through research administration, operations consulting, advancement services, cloud implementation, and Huron Research Suite. Commercial covers financial services, industrials, energy and utilities, consumer markets, private equity, and the public sector. The official healthcare and education pages show how industry expertise is paired with operating and digital execution.
| Segment | FY2025 RBR | Mix | Core demand drivers |
|---|---|---|---|
| Healthcare | $837.5M | 50.4% | Margin pressure, revenue cycle, care transformation, EHR and ERP modernization, managed services |
| Education | $500.2M | 30.1% | Research administration, enterprise systems, operating redesign, advancement and fundraising |
| Commercial | $325.1M | 19.6% | Regulation, complexity reduction, technology transformation, analytics, financial and operating advisory |
How does Huron make money?
Huron earns fees from consulting, managed services, technology implementation, analytics, software, and performance-based engagements. Consulting revenue depends on billable professionals, utilization, rates, scope, and mix. Managed services operate functions such as healthcare revenue cycle or university research administration, creating longer-duration relationships. Digital revenue includes enterprise applications, data, automation, technology managed services, and proprietary software. Fixed-fee and outcome-linked contracts can improve economics but add estimation and timing risk.
Which revenue stream matters most?
In FY2025, Consulting and Managed Services generated $976.9 million of RBR, or 58.7%, while Digital generated $686.0 million, or 41.3%. In Q1 2026, the mix moved to 61.2% and 38.8%, respectively. Consulting and Managed Services grew 21.3% year over year, while Digital was nearly flat as education strength was offset by weaker healthcare and commercial demand. The strategic advantage is the ability to move from advice to implementation and ongoing operations.
| Revenue mechanism | Economic driver | Margin implication | Key risk |
|---|---|---|---|
| Time-and-expense consulting | Billable headcount × utilization × billing rate | High sensitivity to staffing and project mix | Bench time, pricing pressure, delayed starts |
| Fixed-fee and performance-based work | Scope execution and achievement of contractual outcomes | Can reward delivery efficiency and measurable results | Cost overruns and variable-consideration estimates |
| Managed services | Longer-duration operating contracts and service volumes | More recurring, scalable delivery when utilization is managed well | Renewals, service quality, wage inflation |
| Digital and software | Implementations, technology services, subscriptions, product revenue | Potentially scalable but requires platform and talent investment | Vendor dependence, rapid technology change, project cyclicality |
What does Huron's latest quarter show?
The latest reported period is the quarter ended March 31, 2026. Huron's Q1 2026 earnings release and Form 10-Q show strong growth and improved adjusted profitability, alongside a seasonal cash outflow and sharply higher debt.
Growth was broad, but not uniform
RBR increased $48.0 million year over year, including $19.3 million from acquisitions; organic growth was 7.3%. Healthcare rose 13.5%, Commercial 22.3%, and Education 3.8%. Segment operating income increased in all three businesses. Healthcare remained the largest and highest-margin segment at 28.4%. Education margin expanded to 21.6% and Commercial to 16.4%. Digital utilization fell to 74.8% from 78.2%, helping explain why digital revenue grew only 0.2%.
| Metric | Q1 2026 | Q1 2025 | Interpretation |
|---|---|---|---|
| RBR | $443.7M | $395.7M | 12.1% reported growth; 7.3% organic |
| Total revenue | $451.8M | $404.1M | Reimbursable expenses remained a small pass-through item |
| Operating income | $36.6M | $32.7M | Operating income grew 11.8% |
| Net income | $23.2M | $24.5M | Lower because Q1 2025 benefited from an income-tax benefit |
| Adjusted EBITDA | $50.6M | $41.5M | 21.9% growth; margin expanded 90 basis points |
| Diluted / adjusted EPS | $1.34 / $1.73 | $1.33 / $1.68 | Share-count reduction supported per-share results |
How did Huron's operating model evolve?
Huron's present model was built through shifts toward industry depth, integrated digital delivery, and selective acquisitions. The company's official investor resources note that Huron was founded in 2002 and completed its IPO in October 2004. Later changes explain why healthcare and education anchor the portfolio while Commercial provides diversification.
-
2002Foundation. Huron began with 249 professionals. The firm's early identity emphasized expert-led advisory work and senior client relationships.
-
2004Public listing. The IPO created access to capital and a public equity currency for hiring, incentives, and acquisitions.
-
2009James Roth became CEO. Huron increasingly focused on organizations facing disruption or regulatory change, especially healthcare and higher education.
-
2021Portfolio simplification. The Life Sciences divestiture sharpened emphasis on the industries and capabilities where Huron believed it had stronger positions.
-
2022Integrated operating model. Huron organized reporting around Healthcare, Education, and Commercial, with Consulting and Managed Services plus Digital as shared capabilities.
-
2023CEO transition. C. Mark Hussey succeeded Roth after serving as president, COO, and previously CFO, reinforcing an execution and capital-allocation orientation.
-
2025–2026Tuck-in acceleration. Acquisitions expanded fundraising, revenue cycle, financial-services advisory, complexity reduction, payor digital services, and patient access managed services.
Why the 2022 reorganization was strategically important
The current matrix links industry go-to-market teams with shared capabilities, improving cross-selling and accountability while allowing digital and global-delivery talent to work across industries. The trade-off is complexity: incentives, staffing, sales ownership, and delivery quality must remain coordinated. Huron's 2025 10-K says the model still requires refinement and could hurt results if poorly managed.
What gives Huron a competitive advantage?
Huron lacks a patent or network-effect moat. Its advantage combines reputation, specialized knowledge, client relationships, delivery talent, technology-partner credentials, and the ability to execute advisory and implementation work. This matters in regulated, complex, risk-averse healthcare and education institutions. A proven advisor can win repeat work, referrals, and expansion into digital or managed services. The 10-K says price matters, but expertise and measurable outcomes often matter more.
Who are Huron's main competitors?
Huron competes against several groups rather than one direct peer. Strategy firms pursue executive mandates; the Big Four and technology consultancies compete for transformation, ERP, data, and managed services; industry boutiques compete on specialist depth; vendors and internal teams can substitute for implementation. Huron's official technology partnerships are both a referral source and a dependency.
| Competitive group | Where it pressures Huron | Huron's counter-position |
|---|---|---|
| Large strategy and management consultancies | Enterprise strategy, transformation, senior executive access | Deeper concentration in healthcare and education plus implementation capability |
| Big Four and global technology consultancies | Scale, global delivery, ERP, cloud, analytics, managed services | Specialist industry credibility and a more focused delivery model |
| Industry boutiques | Niche expertise, senior attention, lower overhead | Broader capability set and cross-selling across advisory, digital, and operations |
| Software vendors and client in-house teams | Substitution for implementation or recurring operating work | Vendor-neutral advisory, change management, and complex program execution |
Which KPIs best explain Huron's economics?
A consulting firm can grow revenue while weakening if utilization falls, rates stall, senior talent leaves, or acquired headcount is not absorbed. Huron's KPIs therefore connect people, pricing, demand, recurring delivery, and cash conversion. RBR is more useful than total revenue because reimbursable expenses are largely pass-through. Adjusted EBITDA margin should be reviewed beside GAAP income, interest, and cash flow.
Utilization and workforce mix are the operating engine
At March 31, 2026, Huron had 7,989 revenue-generating professionals, up 24.7%. Consulting totaled 2,218, Digital 3,128, and Managed Services 2,643. Managed Services headcount grew almost 60%, reflecting acquisitions and healthcare revenue-cycle expansion. Consulting utilization edged up to 74.6%, while Digital utilization fell 340 basis points to 74.8%, explaining the capability growth divergence.
| KPI | Latest reading | How to interpret it |
|---|---|---|
| RBR growth | 12.1% reported; 7.3% organic in Q1 2026 | Separates underlying demand from acquisition contribution |
| Consulting utilization | 74.6% in Q1 2026 | Higher utilization generally spreads compensation cost across more billable work |
| Digital utilization | 74.8% in Q1 2026 | The year-over-year decline signals softer deployment or hiring ahead of demand |
| Managed Services professionals | 2,643 at March 31, 2026 | Shows growth in recurring operating delivery, especially healthcare revenue cycle |
| Remaining performance obligations | $275.2M at March 31, 2026 | A partial visibility measure; excludes many time-and-expense and constrained variable-fee arrangements |
| Unbilled services | $235.4M at March 31, 2026 | Large balances increase attention to billing milestones, collections, and working-capital conversion |
How strong are cash flow, debt, and capital allocation?
Huron is physically asset-light, but recent acquisitions and repurchases increased balance-sheet risk. FY2025 operating cash flow was $193.4 million. At year-end, debt was about $509.7 million and cash $24.5 million. By March 31, 2026, borrowings reached $856.0 million and cash $26.5 million. Covenant leverage rose from 1.93 to 3.14, though Huron remained compliant and reported 7.57 times interest coverage.
The capital-allocation tension is now central
In 2025, Huron spent $112 million on six tuck-in acquisitions and $166.2 million on repurchases. In Q1 2026, it repurchased another $155.5 million while net bank borrowings were $345 million. Buybacks can increase per-share earnings, but reduce flexibility when combined with acquisitions and seasonal cash needs. Interest expense rose to $8.9 million from $5.6 million, making leverage a central valuation input.
| Financial item | Latest figure | Period | Analytical significance |
|---|---|---|---|
| Cash and equivalents | $26.5M | March 31, 2026 | Modest cash balance means liquidity relies heavily on operating cash flow and the credit facility |
| Borrowings | $856.0M | March 31, 2026 | Includes $471.0M revolver and $385.0M term loan; weighted average rate was 5.2% |
| Covenant leverage | 3.14× | March 31, 2026 | Higher than 1.93× at FY2025 year-end; important constraint on future buybacks and deals |
| Software development | $6.2M | Q1 2026 | Capitalized investment in healthcare and education software products |
| Property and equipment | $5.7M | Q1 2026 | Physical capex remains low relative to revenue, supporting asset-light economics |
| Share authorization remaining | $144.6M | March 31, 2026 | Further repurchases are possible, but debt and cash conversion now matter more |
Who owns Huron stock, and how is it governed?
Huron has one common share class and no founder-controlled super-voting structure, so economic ownership and voting influence are broadly aligned. The 2026 proxy statement reported Vanguard at 9.73%, BlackRock at about 7.6%, and directors and executive officers as a group at 2.07% on the relevant filing dates. Large institutions have meaningful voting influence, but not operational control.
| Holder or group | Reported stake | Source period | Why it matters |
|---|---|---|---|
| The Vanguard Group | 1,679,238 shares; 9.73% | 2026 proxy, based on January 30, 2026 Schedule 13G/A | Large passive ownership increases the importance of governance, capital discipline, and board accountability |
| BlackRock | About 1,352,664 dispositive shares; about 7.6% | 2026 proxy, based on cited Schedule 13G/A | Another major institution with voting influence but no controlling position |
| Directors and executive officers | 343,442 shares; 2.07% | March 9, 2026 record date | Insider ownership is meaningful but does not insulate management from outside shareholders |
| CEO C. Mark Hussey | 76,222 shares; under 1% | March 9, 2026 record date | Equity aligns leadership with per-share outcomes, including repurchase decisions |
How do incentives shape strategy?
The board emphasizes profitable growth, adjusted EBITDA margin, adjusted EPS, cash generation, and shareholder return. The proxy says 84% of shares granted from 2023 through 2025 went to revenue-generating managing directors and principals, versus about 12% to named executive officers. This supports retention but creates dilution. The 2026 slate had eight nominees, with the CEO as the sole employee director.
What opportunities and risks could change Huron's outlook?
Huron's opportunities are tied to client disruption. Healthcare labor pressure, reimbursement complexity, revenue-cycle leakage, EHR modernization, AI, and cost transformation create demand. Universities face research compliance, funding uncertainty, and aging systems. Commercial clients need regulatory, data, cloud, strategy, and operating support. Huron's March 2025 Investor Day strategy prioritized healthcare and education growth, commercial expansion, global digital scale, margin expansion, and disciplined capital deployment through 2029.
Which risks are most material?
The first risk is talent: senior professionals generate demand and maintain relationships. Second is utilization and pricing because short-term compensation is largely fixed. Third is execution on fixed-fee and performance-based work. Fourth is technology and data risk involving sensitive information, third-party platforms, AI, and cybersecurity. Fifth is acquisition risk, including integration, retention, goodwill, contingent payments, and leverage.
Huron's June 2026 RelateCare acquisition illustrates both sides. It expands recurring healthcare delivery and AI-enabled services, but adds another integration task after a busy acquisition year. The key test is whether acquired revenue converts into utilization, retention, margins, and cash.
What matters for valuation and the final takeaway?
A DCF for Huron should begin with RBR because reimbursable expenses add little economic value. Separate organic growth from acquisitions and capability mix. Then model professional count, utilization, rates, compensation, contractors, and global delivery. SG&A and integration costs determine consolidated margin, while cash conversion must reflect bonus timing, receivables, unbilled services, software development, acquisitions, interest, and repurchases.
What should students, researchers, and investors conclude?
Huron occupies a valuable middle ground between global generalists and narrow boutiques. Healthcare and education provide credibility and recurring transformation demand; Commercial and Digital add diversification. FY2025 delivered double-digit reported growth, organic growth, margin expansion, and higher adjusted EPS. Q1 2026 kept demand strong but exposed flat Digital growth, weaker Digital utilization, working-capital pressure, and much higher leverage.
The Huron thesis rests on specialized industry trust, cross-selling across consulting, managed services, and digital work, and disciplined conversion of talent into profitable growth. The story weakens if utilization falls, senior professionals leave, acquisitions fail to integrate, unbilled work does not convert to cash, or debt constrains reinvestment. The most useful forward indicators are organic RBR growth, Digital utilization, Healthcare managed-services expansion, adjusted EBITDA margin, operating cash flow after first-quarter seasonality, unbilled services, covenant leverage, interest expense, and the balance between acquisitions and share repurchases. Those measures reveal whether Huron is compounding a durable specialist platform or merely accelerating reported growth with capital deployment.
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.
